Stock data
Century Therapeutics, Inc. (IPSC)
Century Therapeutics, Inc. (IPSC) reported revenue of US$109.16M and net income of -US$9.58M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$109.16M | — | -US$17.27M | -US$9.58M | — |
| 2024 | US$6.59M | — | -US$138.14M | -US$126.57M | — |
| 2023 | US$2.23M | — | -US$146.55M | -US$136.67M | — |
| 2022 | US$5.20M | — | -US$133.83M | -US$130.93M | — |
| 2021 | — | — | -US$94.88M | -US$95.82M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$34.55M | — |
| 2026-03-31 | — | -US$21.64M | — |
| 2025-12-31 | — | -US$19.18M | — |
| 2025-09-30 | — | -US$34.42M | — |
| 2025-06-30 | — | -US$32.54M | — |
| 2025-03-31 | US$109.16M | US$76.56M | — |
| 2024-12-31 | US$4.17M | -US$36.07M | — |
| 2024-09-30 | US$0.79M | -US$31.23M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.